Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) Completed Phase 3 Trials for Influenza, Human Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT02545543A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age